NanoVibronix UroShield study shows 86% fewer UTIs, 70% fewer blockages, cost savings

ENvue Medical, Inc.

86% reduction in UTI incidence and 70% fewer catheter blockages in independent study published in Australian and New Zealand Continence Journal.
82.8% less bladder irrigations and 52.3% fewer catheter changes reported with UroShield use.
Resource costs reduced by 63.5% over 5 months, easing nursing workload and lowering healthcare expenses.
CEO Brian Murphy highlighted improved patient comfort and reduced catheter-related interventions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.